Animal models of anthracycline cardiotoxicity: Basic mechanisms and cardioprotective activity
- 1 November 1997
- journal article
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 8 (2) , 49-58
- https://doi.org/10.1016/s1058-9813(98)00002-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Doxorubicin-induced Apoptosis in Spontaneously Hypertensive Rats: Differential Effects in Heart, Kidney and Intestine, and Inhibition by ICRF-187Journal of Molecular and Cellular Cardiology, 1996
- Effects of ICRF-187 on the cardiac and renal toxicity of epirubicin in spontaneously hypertensive ratsCancer Chemotherapy and Pharmacology, 1989
- Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) ratsToxicology and Applied Pharmacology, 1988
- Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive ratsToxicology and Applied Pharmacology, 1985
- CLINICAL AND PHARMACOLOGIC INVESTIGATION OF THE EFFECTS OF α‐TOCOPHEROL ON ADRIAMYCIN CARDIOTOXICITY*Annals of the New York Academy of Sciences, 1982
- Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.Journal of Clinical Investigation, 1981
- Cardiotoxic and Possible Leukemogenic Effects of Adriamycin in Nonhuman PrimatesPharmacology, 1980
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967